Table of Contents
ISRN Neuroscience
Volume 2014, Article ID 258040, 4 pages
http://dx.doi.org/10.1155/2014/258040
Research Article

Effect of Coadministration of Neurovite and Lamivudine on the Histomorphology of the Cerebellum of Wistar Rats

1Department of Anatomy, Faculty of Basic Medical Sciences, University of Uyo, PMB 1017, Uyo, Nigeria
2Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo, PMB 1017, Uyo, Nigeria
3Discipline of Clinical Anatomy, School of Laboratory Medicine & Medical Sciences, Nelson R Mandela School of Medicine, Private Bag X54001, Congella 4013, Durban, South Africa

Received 10 September 2013; Accepted 11 December 2013; Published 16 January 2014

Academic Editors: C. Comi, H. Ochi, D. A. Restivo, and A. Unal

Copyright © 2014 A. I. Peter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. D. Ziakas, P. Karsaliakos, and E. Mylonakis, “Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance,” Haematologica, vol. 94, no. 7, pp. 998–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. WHO, “Priotizing second-line antiretroviral drugs for adults and adolescents: a public health approach,” A Report of a WHO Working Group Meeting: World Health Organization, HIV Department, Geneva, Switzerland, pp. 1–44, 2007, http://www.who.int/hiv/pub/meetingreports/Second_Line_Antiretroviral.pdf.
  3. GlaxoSmithkline, “Epivir®/Lamivudine. 3TC drug information online,” 2013, http://www.antimicrobe.org/drugpopup/Lamivudine.pdf.
  4. Aidsmeds, “An almost normal life expectancy for people with HIV?” 2012, http://www.aidsmeds.com/articles/AM_Life_Expectancy_1667_23202.shtml.
  5. G. J. Treisman and A. I. Kaplin, “Neurologic and psychiatric complications of antiretroviral agents,” AIDS, vol. 16, no. 9, pp. 1201–1215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Tozzi, P. Balestra, R. Libertone, and A. Antinori, “Cognitive function in treated HIV patients,” Neurobehavioral HIV Medicine, vol. 2, pp. 95–113, 2010. View at Google Scholar
  7. R. K. Heaton, T. D. Marcotte, M. Rivera Mindt et al., “The impact of HIV-associated neuropsychological impairment on everyday functioning,” Journal of the International Neuropsychological Society, vol. 10, no. 3, pp. 317–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Carr, A. Morey, P. Mallon, D. Williams, and D. R. Thorburn, “Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia,” The Lancet, vol. 357, no. 9266, pp. 1412–1414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Goodkin, M. A. Fletcher, and N. Cohen, “Clinical aspects of psychoneuroimmunology,” The Lancet, vol. 345, no. 8943, pp. 183–184, 1995. View at Google Scholar · View at Scopus
  10. J. Xu and T. Ikezu, “The comorbidity of HIV-associated neurocognitive disorders and alzheimer's disease: a foreseeable medical challenge in post-HAART era,” Journal of Neuroimmune Pharmacology, vol. 4, no. 2, pp. 200–212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Schouten, P. Cinque, M. Gisslen, P. Reiss, and P. Portegies, “HIV-1 infection and cognitive impairment in the cART era: a review,” AIDS, vol. 25, no. 5, pp. 561–575, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. D. Sewell, D. V. Jeste, J. H. Atkinson et al., “HIV-associated psychosis: a study of 20 cases,” American Journal of Psychiatry, vol. 151, no. 2, pp. 237–242, 1994. View at Google Scholar · View at Scopus
  13. E. Brooks, “Vitamin B12 Benefits,” 2010, http://ezinearticles.com/?Vitamin-B12-Benefits&id=5438902.
  14. R. S. Beach, E. Mantero-Atienza, G. Shor-Posner et al., “Specific nutrient abnormalities in asymptomatic HIV-1 infection,” AIDS, vol. 6, no. 7, pp. 701–708, 1992. View at Google Scholar · View at Scopus
  15. J.-H. Gao, L. M. Parsons, J. M. Bower, J. Xiong, J. Li, and P. T. Fox, “Cerebellum implicated in sensory acquisition and discrimination rather than motor control,” Science, vol. 272, no. 5261, pp. 545–547, 1996. View at Google Scholar · View at Scopus
  16. J. A. Fiez, “Cerebellar contributions to cognition,” Neuron, vol. 16, no. 1, pp. 12–15, 1996. View at Google Scholar · View at Scopus
  17. V. Chizhikov and K. J. Millen, “Development and malformations of the cerebellum in mice,” Molecular Genetics and Metabolism, vol. 80, no. 1-2, pp. 54–65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. Schmahmann, “Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 16, no. 3, pp. 367–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. H. Balsters, C. D. Whelan, I. H. Robertson, and N. Ramnani, “Cerebellum and cognition: evidence for the encoding of higher order rules,” Cerebral Cortex, vol. 23, pp. 1433–1443, 2012. View at Google Scholar
  20. S. A. Lipton and H. E. Gendelman, “Dementia associated with the acquired immunodeficiency syndrome,” The New England Journal of Medicine, vol. 332, no. 14, pp. 934–940, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Ellis, D. Langford, and E. Masliah, “HIV and antiretroviral therapy in the brain: neuronal injury and repair,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 33–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. E. O'Hearn and M. E. Molliver, “Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline,” Neuroscience, vol. 55, no. 2, pp. 303–310, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Tang, N. M. H. Graham, A. J. Kirby, L. D. McCall, W. C. Willett, and A. J. Saah, “Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV- 1)-infected homosexual men,” American Journal of Epidemiology, vol. 138, no. 11, pp. 937–951, 1993. View at Google Scholar · View at Scopus
  24. M. Tagliati, D. Simpson, S. Morgello, D. Clifford, R. L. Schwartz, and J. R. Berger, “Cerebellar degeneration associated with human immunodeficiency virus infection,” Neurology, vol. 50, no. 1, pp. 244–251, 1998. View at Google Scholar · View at Scopus
  25. L. Patrick, “Nutrients and HIV: part 2—vitamins A and E, zinc, B-vitamins, and magnesium,” Alternative Medicine Review, vol. 5, no. 1, pp. 39–51, 2000. View at Google Scholar · View at Scopus